306
Views
29
CrossRef citations to date
0
Altmetric
Research Article

In Vitro and In Vivo Evaluation of Glibenclamide in Solid Dispersion Systems

, &
Pages 601-607 | Published online: 03 Jun 2004

References

  • Davis S. N., Granner D. K. Insulin, oral hypoglycemic agents and the pharmacology of endocrine pancreas. The Pharmacological Basis of Therapeutics9th Ed., A. G. Gilman. McGraw‐Hill, New York 1996; 1487–1518
  • Drug Information for Health Care Professional. USP DI. 1999; Vol. I
  • Chiou W. L., Riegelman S. Increased dissolution rates of water‐insoluble cardiac glycosides and steroids via solid dispersions in polyethylene glycol 6000. J. Pharm. Sci. 1971; 60(10)1569–1571, [PUBMED], [INFOTRIEVE]
  • Betageri G. V., Dipali S. R. Preparation and in vitro dissolution profiles of tolazamide‐polyethylene glycol solid dispersion. Drug Dev. Ind. Pharm. 1995; 21(11)1347–1352
  • Save T., Venkitachalam P. Studies on solid dispersions of nifedipine. Drug Dev. Ind. Pharm. 1992; 18: 1663–1679
  • Fernandez J., Vila‐Jato J. L., Banco J., Ford J. L. Some properties of diazepam‐polyethylene glycol solid dispersion and their modification in the presence of stearic acid or polysorbate 80. Drug Dev. Ind. Pharm. 1989; 15: 2491–2513
  • Fernanadez M., Rodriguez I. C., Margarit M. V., Cerezo A. Characterization of solid dispersion of piroxicam/polyethylene glycol 4000. Int. J. Pharm. 1992; 84: 197–202, [CROSSREF]
  • Araias M. J., Gines J. M., Moyano J. R., Martinez J. I., Rabasco A. M. Influence of the preparation method of solid dispersions on their dissolution rate: study of trimetrene‐d‐mannitol system. Int. J. Pharm. 1995; 123: 25–31, [CROSSREF]
  • Dordunoo S. K., Ford J. L., Rubinstein M. H. Preformulation studies on solid dispersions containing traimterene or temazepam in polyethylene glycols or gelucire 44/14 for liquid filling of hard gelatine capsules. Drug Dev. Ind. Pharm. 1991; 17: 1685–1713
  • Gattafosse Technical Dossier. Gelucire Pharmaceutical Excipients for Oral Semisolid Formulation
  • Sheen P. C., Kim E. I., Petillo J. J., Serajuddin A. T.M. Bioavailability of poorly water‐soluble drug for tablet and solid dispersion in human. J. Pharm. Sci. 1991; 80(7)712–714, [PUBMED], [INFOTRIEVE]
  • Reynolds J. E. Martindale: The Extra Pharmacopoeia30th Ed. The Pharmaceutical Press, London 1993; 1384
  • Rabasco A. M., Gines J. M., Fernandez A., Hogado M. A. Dissolution rate of diazepam from PEG 6000 solid dispersion. Int. J. Pharm. 1991; 67: 201–205, [CROSSREF]
  • Sheu M.‐T., Yeh C.‐M., Sokoloski T. D. Characterization and dissolution of fenofibrate solid dispersion systems. Int. J. Pharm. 1994; 103: 137–246, [CROSSREF]
  • Jachowics R., Nurberg E., Hoppe R. Solid dispersion of oxazepam. Int. J. Pharm. 1994; 99: 321–325, [CROSSREF]
  • Dressman J. B., Amidon G. L., Reppas C., Shan V. P. Dissolution testing as aprognostic tool for oral drug absorption; Immediate release dosage forms. Pharm. Res. 1998; 15(1)11–22, review[PUBMED], [INFOTRIEVE], [CROSSREF]
  • Qureshi S., McGilveray I. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product. Eur. J. Pharm. Sci. 1999; 7: 249–258, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Blume H., Ali S., Siewert M. Pharmaceutical quality of glibenclamide products: a multinational postmarketing comparative study. Drug Dev. Ind. Pharm. 1993; 19(20)2713–2741
  • El‐sayed Y. M., suleiman M. S., Hasam M. M., Abdel‐Hamid M. E., Najib N. M., Sallem E. S., Subair M. S. Comparison of the pharamacokinetics and pharmacodynamics of two commercial products containing glibenclamide. Int. J. Clin. Pharmacol. Therm. Toxicol. 1989; 27(11)551–557
  • Al‐Kamis K., El‐sayed Y., Al‐Rashood K., Al‐Yamani M. High performance liquid chromatographic method for determination of glibenclamide in human plasma. Anal. lett. 1994; 27(7)1277–1293
  • Chiou W., Riegelman S. Pharmaceutical application of solid dispersion systems. J. Pharm. Sci. 1971; 60(9)1281–1302, [PUBMED], [INFOTRIEVE]
  • Neugebauer G., Betzien G., Hrstka V., kauhmann B., Von mdlendorff E., Abshagen U. Absolute bioavailability and bioequivalence of glibenclamide (Semi‐Euglycon® N). Int. J. Clin. Pharmacol. Ther. Toxicol. 1985; 23(9)453–460, [PUBMED], [INFOTRIEVE]
  • Shaheen O., Othman, Sadeq, Jalal I., Awidi A., Al‐Turk W. Comparison of pharmacokinetics and pharmacodynamics of a conventional and a new rapidly dissolving glibenclamide preparation. Int. J. Pharm. 1987; 38: 123–131, [CROSSREF]
  • Marchetti P., Giannarelli R., Carlo A., Navalesi R. Pharamacokinetics optimization of oral hypoglycemic therapy. Clin. Pharmacokinet. 1991; 21(4)308–317, [PUBMED], [INFOTRIEVE]
  • Podczeck F. Comparison of in vitro dissolution profiles by calculating mean dissolution time (MDT) or mean residence time (MRT). Int. J. Pharm. 1993; 97: 93–100, [CROSSREF]
  • Santosh J. V. Dissolution testing and assessment of bioavailability/bioequivalence. Pharmaceutical Dissolution Testing, U. V. Banker. Marcel Dekker, Inc., New York 1992; 391–411

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.